Keren Rouvinov

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

Daniel Keizman, Maya Gottfried, Maya Ish‐Shalom et al. · The Oncologist · 2013 · 67 citations · Full text

Medicine, Oncology, Pharmacology +10

A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Mark Krauthamer, Keren Rouvinov, Samuel Ariad et al. · Oncology · 2013 · 56 citations

Medicine, Immunology, Oncology +15

Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database

Daniel Keizman, M Ø Fosboel, Hermann Reichegger et al. · Prostate Cancer and Prostatic Diseases · 2017 · 48 citations

Medicine, Oncology, Radiation Oncology +16

Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer

Bar Kaufman, Orli Abramov, Anna Ievko et al. · Science Advances · 2023 · 40 citations · Full text

Medicine, Immunology, Oncology +17